> top > docs > PubMed:23537957 > spans > 153-430 > annotations

PubMed:23537957 / 153-430 JSONTXT

Annnotations TAB JSON ListView MergeView

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T1 0-277 DRI_Approach denotes The genomic sequences of low and high passages of the United States infectious laryngotracheitis (ILT) vaccine strains CEO and TCO were determined using hybrid next generation sequencing in order to define genomic changes associated with attenuation and reversion to virulence.

Goldhamster2_Cellosaurus

Id Subject Object Predicate Lexical cue
T2 98-101 CVCL_F909|Transformed_cell_line|Homo sapiens denotes ILT
T3 127-130 CVCL_HE32|Cancer_cell_line|Homo sapiens denotes TCO
T4 214-221 CVCL_0238|Cancer_cell_line|Homo sapiens denotes changes

GoldHamster

Id Subject Object Predicate Lexical cue
T13 111-118 D013180 denotes strains
T14 111-118 D013180 denotes strains
T15 119-122 PR:A5HZ59 denotes CEO
T17 127-130 CVCL_HE32 denotes TCO
T16 127-130 CHEBI:73156 denotes TCO
T18 127-130 C537842 denotes TCO
T19 153-159 37965 denotes hybrid
T20 153-159 D002678 denotes hybrid
T21 267-276 GO:0009405 denotes virulence
T22 267-276 GO:0009406 denotes virulence
T23 267-276 GO:0016032 denotes virulence

Allie

Id Subject Object Predicate Lexical cue
SS1_23537957_1_0 68-96 expanded denotes infectious laryngotracheitis
SS2_23537957_1_0 98-101 abbr denotes ILT
AE1_23537957_1_0 SS1_23537957_1_0 SS2_23537957_1_0 abbreviatedTo infectious laryngotracheitis,ILT